GEODE CAPITAL MANAGEMENT, LLC
Position in MTNB — Matinas BioPharma Holdings, Inc.
CIK 1214717
BOSTON, MA
Position in MTNB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$30,070
-$2,514 QoQ
Shares Held
49,135
-24.6% QoQ
Ownership
0.334%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 25 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MTNB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. MTNB ranks #493 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in MTNB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,070 | 49,135 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $32,584 | 65,170 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,797 | 55,970 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $105,782 | 55,970 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $49,388 | 55,494 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $24,304 | 46,741 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,167 | 43,467 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $165,420 | 46,729 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $362,023 | 2,291,286 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $578,708 | 2,135,457 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $340,526 | 1,576,513 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $254,863 | 1,960,492 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $705,222 | 1,958,952 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $848,283 | 1,804,858 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $902,429 | 1,804,858 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,074,964 | 1,690,196 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,225,436 | 1,551,186 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,311,064 | 1,630,677 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,602,731 | 1,586,863 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,813,167 | 1,394,744 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,022,193 | 1,318,959 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,329,211 | 1,265,916 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,525,010 | 1,121,331 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $826,831 | 1,079,415 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $834,387 | 1,079,415 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $647,649 | 1,079,415 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||